Repeated annual influenza vaccination and vaccine effectiveness: review of evidence
暂无分享,去创建一个
Edward A Belongia | D. Skowronski | E. Belongia | H. McLean | M. Sundaram | G. De Serres | Gaston De Serres | C. Chambers | Danuta M Skowronski | Huong Q McLean | Catharine Chambers | Maria E Sundaram
[1] Nicholas S. Kelley,et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. , 2016, The Lancet. Infectious diseases.
[2] J. McDonald,et al. Diagnostic Methods in an Influenza Vaccine Trial* , 1955, British medical journal.
[3] L. Burney. Influenza immunization: Statement. , 1960, Public health reports.
[4] S. Lindstrom,et al. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. , 2011, Vaccine.
[5] A. Monto,et al. 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[7] D. Skowronski,et al. A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] A. Monto,et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] Christine Miller,et al. ASSESSMENT OF INACTIVATED INFLUENZA-A VACCINE AFTER THREE OUTBREAKS OF INFLUENZA A AT CHRIST'S HOSPITAL , 1979, The Lancet.
[10] J. Katz,et al. Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11. , 2016, Vaccine.
[11] S. Kent,et al. Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity , 2015, Expert review of vaccines.
[12] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[13] Kui-biao Li,et al. Concurrent and cross-season protection of inactivated influenza vaccine against A(H1N1)pdm09 illness among young children: 2012-2013 case-control evaluation of influenza vaccine effectiveness. , 2015, Vaccine.
[14] R. Greenlee,et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. , 2009, The Journal of infectious diseases.
[15] M. D. Eaton,et al. AN ANALYSIS OF SEROLOGICAL REACTIONS AFTER VACCINATION AND INFECTION WITH THE VIRUS OF INFLUENZA A , 1942 .
[16] A. Monto,et al. Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination. , 2015, The Journal of infectious diseases.
[17] D. Skowronski,et al. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season. , 2015, The Journal of infectious diseases.
[18] A. Osterhaus,et al. Annual influenza vaccination affects the development of heterosubtypic immunity. , 2012, Vaccine.
[19] W. Ndifon. A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants , 2015, Journal of The Royal Society Interface.
[20] A. Monto,et al. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. , 2016, The Journal of infectious diseases.
[21] Christine Miller,et al. INFLUENZA AT CHRIST'S HOSPITAL: MARCH, 1974 , 1976, The Lancet.
[22] John S. Tsang,et al. Utilizing population variation, vaccination, and systems biology to study human immunology , 2015, Trends in immunology.
[23] A D LANGMUIR,et al. THE EPIDEMIOLOGICAL BASIS FOR THE CONTROL OF INFLUENZA. , 1964, American journal of public health and the nation's health.
[24] D. Skowronski,et al. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). , 2012, The Journal of infectious diseases.
[25] Florian Krammer,et al. Neutralizing Antibodies Against Previously Encountered Influenza Virus Strains Increase over Time: A Longitudinal Analysis , 2013, Science Translational Medicine.
[26] T. Friedrich,et al. Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] I. Julkunen,et al. Effectiveness of Pandemic and Seasonal Influenza Vaccines in Preventing Laboratory-Confirmed Influenza in Adults: A Clinical Cohort Study during Epidemic Seasons 2009–2010 and 2010–2011 in Finland , 2014, PloS one.
[28] A S Perelson,et al. Variable efficacy of repeated annual influenza vaccination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[29] W Carman,et al. Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom , 2012, Epidemiology and Infection.
[30] A. Osterhaus,et al. Annual Vaccination against Influenza Virus Hampers Development of Virus-Specific CD8+ T Cell Immunity in Children , 2011, Journal of Virology.
[31] A. Monto,et al. Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. , 2016, The Journal of infectious diseases.
[32] J. Davies,et al. Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses , 1989, Epidemiology and Infection.
[33] Jin Hyang Kim,et al. Strategies to alleviate original antigenic sin responses to influenza viruses , 2012, Proceedings of the National Academy of Sciences.
[34] D. Skowronski,et al. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. , 2014, The Journal of infectious diseases.
[35] A. Monto,et al. Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility. , 2015, The Journal of infectious diseases.
[36] A. Monto,et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] F. Pozo,et al. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. , 2012, Vaccine.
[38] E. Belongia,et al. Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. , 2009, Vaccine.
[39] R. Brunham,et al. Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. , 2011, The Journal of infectious diseases.
[40] R B Couch,et al. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. , 1997, Vaccine.
[41] G. Rimmelzwaan,et al. Yearly influenza vaccinations: a double-edged sword? , 2009, The Lancet. Infectious diseases.
[42] A. García-Sastre. Systems vaccinology informs influenza vaccine immunogenicity , 2016, Proceedings of the National Academy of Sciences.
[43] E. Hak,et al. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[44] Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005. , 2005, Canada communicable disease report = Releve des maladies transmissibles au Canada.
[45] Richard K. Zimmerman,et al. Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type , 2014, The Journal of infectious diseases.
[46] C. A. Russell,et al. Antibody landscapes after influenza virus infection or vaccination , 2014, Science.
[47] J. Castilla,et al. Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010–2011: a population-based test-negative case–control study , 2013, BMC Public Health.
[48] K. Davis,et al. The Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors. , 2014, Vaccine.
[49] B. Cowling,et al. Influenza vaccine effectiveness in the community and the household. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[50] D. Skowronski,et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] T. Hoskins,et al. Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain. , 1973, Lancet.
[52] E. Pariani,et al. Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season. , 2016, Vaccine.
[53] M. Valenciano,et al. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[54] A. Monto,et al. Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated. , 2016, The Journal of infectious diseases.
[55] Judith M. Fonville,et al. The confounded effects of age and exposure history in response to influenza vaccination. , 2016, Vaccine.
[56] R. Compans,et al. Original Antigenic Sin Responses to Influenza Viruses1 , 2009, The Journal of Immunology.
[57] S. Halstead,et al. The Wages of Original Antigenic Sin , 2010, Emerging infectious diseases.
[58] I. Longini,et al. Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981. , 1985, American journal of epidemiology.
[59] Suresh Mahalingam,et al. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes , 2010, The Lancet Infectious Diseases.
[60] D. Skowronski,et al. Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses , 2014, PloS one.
[61] F. Pozo,et al. Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons. , 2016, Vaccine.